The self-efficacy model of medication adherence in chronic mental illness
Terence V McCann BA, MA, PhD, RN
Search for more papers by this authorEileen Clark BA, MLitt, MSocSci, GDipEnvMgt
Search for more papers by this authorSai Lu BMed(Hons), PhD
Search for more papers by this authorTerence V McCann BA, MA, PhD, RN
Search for more papers by this authorEileen Clark BA, MLitt, MSocSci, GDipEnvMgt
Search for more papers by this authorSai Lu BMed(Hons), PhD
Search for more papers by this authorAbstract
Aim. In this position paper, the self-efficacy model of medication adherence in chronic mental illness is presented, and its application to antipsychotic medication adherence is considered.
Background. Poor adherence to antipsychotic medications is common in chronic mental illness. Major implications of this are relapse and re-hospitalisation. Several conceptual frameworks have been developed about adherence and, in some instances, have been incorporated in medication taking studies, but have resulted in inconsistent outcomes.
Method. This paper draws on a review of literature from databases to inform the development of the self-efficacy model of medication adherence. Inclusion and exclusion criteria were developed from primary and secondary research questions.
Results. The model places the person with chronic mental illness as an active participant central to the process of medication taking. It has three components: core factors, contextual influences and a continuum. The factors comprise a central factor, self-efficacy and four interrelated supporting influences: perceived medication efficacy; access to, and relationships with, health professionals; significant other support and supported living circumstances. The factors are affected by three broad contextual influences – personal issues, medication side-effects and complexity, and social stigma – which affect the way individuals take their medications. A continuum exists between adherence and non-adherence.
Conclusion. The model positions service users at the heart of adherence by giving prominence to self-efficacy, medication efficacy and to immediate social, psychological and environmental supports. Further work is needed to validate, refine and extend the model.
Relevance to clinical practice. For practitioners involved in prescribing and medication management in people with chronic mental illness, the model provides a theoretical framework to strengthen adherence. It highlights the need to consider broader influences on medication taking. Moreover, it places the person with chronic mental illness as an active participant at the centre of strategies to enhance adherence.
References
- Aikens JE, Nease DE Jr, Nau DP, Klinkman MS & Schwenk TL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Annals of Family Medicine 3, 23–30.
- Ajzen I (1985) From Intentions to Actions: A Theory of Planned Behavior. Springer-Verlag, Berlin.
- Bachrach LL (1988) Defining chronic mental illness: a concept paper. Hospital and Community Psychiatry 39, 383–388.
- Bandura A (1994) Self-Efficacy. Academic Press, New York.
- Barofsky I (1978) Compliance, adherence, and the therapeutic alliance: steps in the development of self-care. Social Science and Medicine 12, 369–376.
- Becker H, Stuifbergen A, Oh HS & Hall S (1993) Self-rated abilities for health practices: a health self-efficacy measure. Health Values 17, 42–50.
- Brown C, Battista DR, Bruehlman R, Sereika SS, Thase ME & Dunbar-Jacob J (2005) Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Medical Care 43, 1203–1207.
- Christison GW, Darrell GK & Wyatt RJ (1991) When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophrenia Bulletin 17, 217–245.
- Cohen NL, Parikh SV & Kennedy SH (2000) Medication compliance in mood disorders relevance of the Health Belief Model and other determinants. Primary Care Psychiatry 6, 101–110.
- Commonwealth of Australia (1993a) Community Attitudes to Mental Illness: A Report on Qualitative Research. Department of Health, Housing, Local Government and Community Services, AGPS, Canberra, Australia.
- Commonwealth of Australia (1993b) Community Attitudes to Mental Illness: Stage 2 – Quantitative Research Report. Department of Health, Housing, Local Government and Community Services, AGPS, Canberra, Australia.
- Corrigan PW, Liberman RP & Engel JD (1990) From noncompliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 41, 1203–1211.
- Coulton CJ, Holland TP & Fitch VF (1984) Person-environment congruence and psychiatric patient outcome in community care homes. Administration in Mental Health 12, 71–88.
- Cramer JA & Rosenheck R (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services 49, 196–201.
- Crisp AH, Gelder MG, Rix S, Meltzer HI & Rowlands OJ (2000) Stigmatisation of people with mental illness. British Journal of Psychiatry 177, 4–7.
- Crisp A, Gelder M, Goddard E & Meltzer H (2005) Stigmatization of people with mental illnesses: a follow-up study within the Changing Minds campaign of the Royal College of Psychiatrists. World Psychiatry 4, 106–113.
- Dixon L, Weiden P, Torres M & Lehman A (1997) Assertive community treatment and medication compliance in the homeless mentally ill. American Journal of Psychiatry 154, 1302–1304.
- Dolder CR, Lacro JP, Dunn LB & Jeste DV (2002) Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry 159, 103–108.
- Dolder CR, Lacro JP, Leckband S & Jeste DV (2003) Interventions to improve antipsychotic medication adherence: review of recent literature. Journal of Clinical Psychopharmacology 23, 389–399.
-
Edwards J &
McGorry P (2002) Implementing Early Psychosis Services. Dunitz, London.
10.1201/b14315 Google Scholar
- Farabee D & Shen H (2004) Antipsychotic medication adherence, cocaine use, and recidivism among a parolee sample. Behavioural Sciences and the Law 22, 467–476.
- Fenton WS, Blyler CR & Heinssen RK (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23, 637–651.
- Frank AF & Gunderson JG (1990) The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry 47, 228–236.
- Gasquet I, Haro JM, Novick D, Edgell ET, Kennedy L & Lepine JP (2005) Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. International Clinical Psychopharmacology 20, 199–205.
- Geddes J, Freemantle N, Harrison P & Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. British Medical Journal 321, 1371–1376.
- Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P & Jeste DV (2004) Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161, 692–699.
- Glanz K & Rimer BK (1995) Theory at a Glance: A Guide for Health Education Practice. National Cancer Institute, Washington, DC.
- Glanz K, Lewis FM & Rimer BK (1997) Health Behavior and Health Education: Theory, Research, and Practice. Jossey-Bass, San Francisco.
- Goffman E (1968) Stigma: Notes on the Management of Spoiled Identity. Pelican, New York.
- Gray R, Wykes T & Gournay K (2002) From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing 9, 277–284.
- Green JH (1988) Frequent hospitalization and noncompliance with treatment. Hospital and Community Psychiatry 39, 963–966.
- Groom G, Hickie I & Davenport T (2003) Out of Hospital, out of Mind: A Report Detailing Mental Health Services in Australia in 2002 and Community Priorities for National Mental Health Policy for 2002-2003. Mental Health Council of Australia, Deakin West, Australian Capital Territory.
- Hall NJ, Rubin GP, Hungin AP & Dougall A (2007) Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study. BMC Gastroenterology 7, 20.
- Harrigan SM, McGorry PD & Krstev H (2003) Does treatment delay in first-episode psychosis really matter? Psychological Medicine 33, 97–110.
- Haynes RB, McKibbon KA & Kanani R (1996) Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348, 383–386.
- Haynes RB, McDonald H, Garg AX & Montague P (2001) Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews CD000011.
- Haynes RB, Yao X, Degani A, Kripalani S, Garg A & McDonald HP (2005) Interventions for enhancing medication adherence (Review). Cochrane Database of Systematic Reviews CD000011. DOI: DOI: 000010.001002/14651858.CD14000011.pub14651852.
- Herr T & Wagner SL (2003) Self-Efficacy as a Welfare-to-Work Goal: Emphasizing Both Psychology and Economics in Program Design Chicago, IL. Available at: http://www.pmatch.org/self_effic_june_othree.pdf (accessed 18 February 2006).
- Higgins N, Livingston G & Katona C (2004) Concordance therapy: an intervention to help older people take antidepressants. Journal of Affective Disorders 81, 287–291.
- Hunot VM, Horne R, Leese MN & Churchill RC (2007) A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion Journal of Clinical Psychiatry 9, 91–99.
- Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G & Gray RJ (2006) Medication adherence in schizophrenia: exploring patients’, carers’ and professionals’ views. Schizophrenia Bulletin 32, 786–794.
- Lacro JP, Dunn LB, Dolder CR, Leckband SG & Jeste DV (2002) Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63, 892–909.
- Latter S, Maben J, Myall M & Young A (2007) Perceptions and practice of concordance in nurses’ prescribing consultations: findings from a national questionnaire survey and case studies of practice in England. International Journal of Nursing Studies 44, 9–18.
- Leucht S, Pitschel-Walz G, Abraham D & Kissling W (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophrenia Research 35, 51–68.
- Leventhal H & Cameron L (1987) Behavioral theories and the problem of compliance. Patient Education and Counseling 10, 117–138.
- Lipton FR, Siegel C, Hannigan A, Samuels J & Baker S (2000) Tenure in supportive housing for homeless persons with severe mental illness. Psychiatric Services 51, 479–486.
- Loffler W, Kilian R, Toumi M & Angermeyer MC (2003) Schizophrenic patients’ subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36, 105–112.
- Lorig K & Holman H (1993) Arthritis self-management studies: a twelve-year review. Health Education Quarterly 20, 17–28.
- Marshall M & Lockwood A (2002) Assertive Community Treatment for People With Severe Mental Disorders (Cochrane Review). Available at: http://www.cochrane.org/reviews/en/ab001089.html (accessed 20 November 2006).
- McAllister M & Chatterton R (1996) Clozapine: exploring clients’ experiences of treatment. Australian and New Zealand Journal of Mental Health Nursing 5, 136–142.
- McIntosh AM, Conlon L, Lawrie SM & Stanfield AC (2006) Compliance therapy for schizophrenia (Review). Cochrane Database of Systematic Reviews CD003442. DOI: DOI: 003410.001002/14651858.CD14003442.pub14651852.
- Mental Health Council of Australia (2006) Time for Services: Solving Australia’s Mental Health Crisis. Mental Health Council of Australia, Deakin West, ACT, Australia.
- Mental Health Council of Australia & The Brain and Mind Institute (2005) Not for Service: Experiences of Injustice and Despair in Mental Health Care in Australia. Mental Health Council of Australia, Canberra. Available at: http://www.mhca.org.au/notforservice/summary/index.html (accessed 14 November 2006).
- Miklowitz DJ, George EL, Richards JA, Simoneau TL & Suddath RL (2003) A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry 60, 904–912.
- Moore EJ (1990) Using self-efficacy in teaching self-care to the elderly. Holistic Nursing Practice 4, 22–29.
- Myers L & Midence K (1998) Adherence to Treatment in Medical Conditions. Harwood Academic Publishers, Amsterdam.
- Owen RR, Fischer EP, Booth BM & Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services 47, 853–858.
- Pekkala E & Merinder L (2002) Psychoeducation for Schizophrenia. Cochrane Database of Systermatic Reviews CD002831. DOI: DOI: 10.1002/14651858.CD002831.
- Perkins DO (1999) Adherence to antipsychotic medications. Journal of Clinical Psychiatry 60(Suppl. 21), 25–30.
- Perkins DO (2002) Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry 63, 1121–1128.
- Phatak HM & Thomas J III (2006) Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Annals of Pharmacotherapy 40, 1737–1742.
- Pinikahana J, Happell B, Taylor M & Keks NA (2002) Exploring the complexity of compliance in schizophrenia. Issues in Mental Health Nursing 23, 513–528.
- Pollock K & Grime J (2004) Meeting the Treatment Information Needs of Users of Specialist Mental Health Services. A Study of Users’ Experience of Information Provision Within a Complex System of Care: Final Report of the Concordance Research Fellowship. Department of Medicines Management, Keele University, Keele, Staffordshire, UK.
- Razali MS & Yahya H (1995) Compliance with treatment in schizophrenia: a drug intervention program in a developing program. Acta Psychiatrica Scandinavica 91, 331–335.
- Renton CA, Affleck FW, Carstairs GM & Forrest AD (1963) A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39, 548–600.
- Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM & Fleischhacker WW (2004) Compliance in schizophrenia: psychopathology, side effects, and patients’ attitudes toward the illness and medication. Journal of Clinical Psychiatry 65, 1211–1218.
- Rijcken CA, Tobi H, Vergouwen AC & De Jong-van den Berg LT (2004) Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients’ compliance by using computerised pharmacy data. Pharmacoepidemiology and Drug Safety 13, 365–370.
- Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D & Lieberman JA (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56, 241–247.
- Rogers A, Day JC, Williams B, Randall F, Wood P, Healy D & Bentall RP (1998) The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science and Medicine 47, 1313–1323.
- Rogers A, Day J, Randall F & Bentall RP (2003) Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication: a qualitative study. Social Psychiatry Psychiatric Epidemiology 38, 720–727.
- Rosenstock I (1974) Historical origins of the health belief model. In The Health Belief Model and Personal Health Behaviour ( MH Becker ed.). C. B. Slack Inc, New Jersey, pp. 1–8.
- Schmall VL (1995) Family caregiver education and training: enhancing self-efficacy. Journal of Case Management 4, 156–162.
- Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B & Rogers RW (1982) The self-efficacy scale: construction and validation. Psychological Reports 51, 663–671.
- Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ & Meyers BS (2001) Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services 52, 1615–1620.
- Strang JS, Falloon IR, Moss HB, Razani J & Boyd JL (1981) The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin 17, 87–88.
- Sulliger N (1988) Relapse. Journal of Psychosocial Nursing 26, 20–23.
- Tait L, Birchwood M & Trower P (2003) Predicting engagement with services for psychosis: insight, symptoms and recovery style. British Journal of Psychiatry 182, 123–128.
- Tanzman B (1993) An overview of surveys of mental health consumers’ preferences for housing and support services. Hospital and Community Psychiatry 44, 450–455.
- Tattan TMG & Creed FH (2001) Negative symptoms of schizophrenia and compliance with medication. Schizophrenia Bulletin 27, 149–155.
- Warner R (2004) Recovery From Schizophrenia: Psychiatry and Political Economy. Brunner-Routledge, New York.
- Weiden PJ, Dixon L, Frances A, Appelbaum P, Haas G & Rapkin B (1991) Neuroleptic noncompliance in schizophrenia. In Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology ( CA Tamminga & SC Schulz eds). Raven Press, New York, pp. 285–296.
- Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M & Frances A (1994) Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin 20, 297–310.
- Weiden PJ, Kozma C, Grogg A & Locklear J (2004a) Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55, 886–891.
- Weiden PJ, Mackell JA & McDonnell DD (2004b) Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 66, 51–57.
- Weiss KA, Smith TE, Hull JW, Piper AC & Huppert JD (2002) Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophrenia Bulletin 28, 341–349.
- Whitaker R (2004) The case against antipsychotic drugs: a 50-year record of doing more harm than good. Medical Hypotheses 62, 5–13.
- Williams CC & Collins AA (2002) The social construction of disability in schizophrenia. Qualitative Health Research 12, 297–309.
- World Health Organization (2003) Adherence to Long-Term Therapies: Evidence for Action ( E Sabate ed.). World Health Organization, Geneva, pp. 7–10.
- Xiang M, Ran M & Li S (1994) A controlled evaluation of psychoeducational family intervention in a rural Chinese community. British Journal of Psychiatry 165, 544–548.
- Yamada K, Watanabe K, Nemoto N, Fujita H, Chikaraishi C, Yamauchi K, Yagi G, Asai M & Kanba S (2006) Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Research 141, 61–69.
- Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF & Wu CC (2005) Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry and Clinical Neurosciences 59, 403–409.
- Young JL, Zonana HV & Shepler L (1986) Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law 14, 105–122.
- Zygmunt A, Olfson M, Boyer CA & Mechanic D (2002) Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry 159, 1653–1664.